Pancreatic Cancer Research

ResearcherVirginia TechActive in the last 2 years

Khan Mohammad Imran

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0755-8499; OpenAlex author ID A5032749393. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: 1 paper

Papers 3

  1. Irreversible electroporation promotes a pro-inflammatory tumor microenvironment and anti-tumor immunity in a mouse pancreatic cancer model. Co-author DOI 10.3389/fimmu.2024.1352821↗
  2. NLRX1 functions as a tumor suppressor in Pan02 pancreatic cancer cells. Co-author DOI 10.3389/fonc.2023.1155831↗
  3. Exploration of Novel Pathways Underlying Irreversible Electroporation Induced Anti-Tumor Immunity in Pancreatic Cancer. Co-author DOI 10.3389/fonc.2022.853779↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Irving C Allen · 3 shared papers, 2022–2024 · strength 0.57
  2. Margaret A. Nagai-Singer · 2 shared papers, 2022–2023 · strength 0.39
  3. Rafael V. Davalos · 2 shared papers, 2022–2024 · strength 0.37
  4. Alissa Hendricks-Wenger · 1 shared paper, 2024 · strength 0.18
  5. Natalie Beitel-White · 1 shared paper, 2024 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.